Cervical Cancer Data Inject Fresh Life Into Sanofi's Libtayo

More Positive Phase III Findings For Regeneron-Partnered PD-1 Inhibitor

 
• By Kevin Grogan
  
Lyon France, 3 October 2017: White logo of the french multinational pharmaceutical company Sanofi on their glass office building in Lyon France
• Source: Archive

More from Immuno-oncology

More from Anticancer